A Glutamate Receptor Antagonist, S-4-Carboxyphenylglycine (S-4-CPG), Inhibits Vasospasm After Subarachnoid Hemorrhage in Haptoglobin 2-2 Mice (vol 73, pg 719, 2013)

被引：0

作者：

Garzon-Muvdi, T.

Pradilla, G.

Ruzevick, J. J.

机构：

来源：

NEUROSURGERY | 2013年 / 73卷 / 06期

关键词：

D O I：

10.1227/01.neu.0000438022.56736.47

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：E1098 / E1098

页数：1

共 10 条

[1] A Glutamate Receptor Antagonist, S-4-Carboxyphenylglycine (S-4-CPG), Inhibits Vasospasm After Subarachnoid Hemorrhage in Haptoglobin 2 to 2 Mice
Garzon-Muvdi, Tomas
Pradilla, Gustavo
Ruzevick, Jacob J.
Bender, Matthew
Edwards, Lindsay
Grossman, Rachel
Zhao, Ming
Rudek, Michelle A.
Riggins, Gregory
Levy, Andrew
Tamargo, Rafael J.
NEUROSURGERY, 2013, 73 (04) : 719 - 728
[2] A Glutamate Receptor Antagonist, S-4-Carboxyphenylglycine (S-4-CPG), Inhibits Vasospasm After Subarachnoid Hemorrhage in Haptoglobin 2 to 2 Mice COMMENT
Du, Rose
NEUROSURGERY, 2013, 73 (04) : 729 - 729
[3] Inhibition of Vasospasm in Haptoglobin 2-2 Mice Using S-4-CPG (S-4 carboxyphenylgicine), a Metabotropic Glutamate Receptor Antagonist
Garzon-Muvdi, Tomas
Pradilla, Gustavo
Ruzevick, Jake
Bender, Matthew
Edwards, Lindsay
Tamargo, Rafael J.
JOURNAL OF NEUROSURGERY, 2011, 115 (02) : A436 - A436
[4] Inhibition of Leukocyte Migration by Blocking VLA-4 Prevents Vasospasm after Subarachnoid Hemorrhage in Haptoglobin 2-2 Mice
Froehler, Michael T.
Kooshkabadi, Ali
Tamargo, Rafael J.
STROKE, 2009, 40 (04) : E144 - E144
[5] CONTROLLED DELIVERY OF NITRIC OXIDE INHIBITS LEUKOCYTE MIGRATION AND PREVENTS VASOSPASM IN HAPTOGLOBIN 2-2 MICE AFTER SUBARACHNOID HEMORRHAGE
Momin, Eric N.
Schwab, Kristin E.
Chaichana, Kaisorn L.
Miller-Lotan, Rachel
Levy, Andrew P.
Tamargo, Rafael J.
NEUROSURGERY, 2009, 65 (05) : 937 - 945
[6] CONTROLLED DELIVERY OF NITRIC OXIDE INHIBITS LEUKOCYTE MIGRATION AND PREVENTS VASOSPASM IN HAPTOGLOBIN 2-2 MICE AFTER SUBARACHNOID HEMORRHAGE COMMENTS
Dacey, Ralph G., Jr.
Macdonald, R. Loch
NEUROSURGERY, 2009, 65 (05) : 945 - 945
[7] The group I metabotropic glutamate receptor antagonist S-4-CPG modulates the locomotor response produced by the activation of D1-like, but not D2-like, dopamine receptors in the rat nucleus accumbens
David, HN
Abraini, JH
EUROPEAN JOURNAL OF NEUROSCIENCE, 2001, 13 (11) : 2157 - 2164
[8] (S)-4-CARBOXY-3-HYDROXYPHENYLGLYCINE, AN ANTAGONIST OF METABOTROPIC GLUTAMATE-RECEPTOR (MGLUR)1A AND AN AGONIST OF MGLUR2, PROTECTS AGAINST AUDIOGENIC-SEIZURES IN DBA/2 MICE
THOMSEN, C
KLITGAARD, H
SHEARDOWN, M
JACKSON, HC
ESKESEN, K
JACOBSEN, P
TREPPENDAHL, S
SUZDAK, PD
JOURNAL OF NEUROCHEMISTRY, 1994, 62 (06) : 2492 - 2495
[9] 1-Alkyl-3-amino-5-aryl-1H-[1,2,4]triazoles: Novel synthesis via cyclization of N-acyl-S-methylisothioureas with alkylhydrazines and their potent corticotropin-releasing factor-1 (CRF1) receptor antagonist activities (vol 11, pg 3165, 2001)
Chen, Chen
Dagnino, Raymond, Jr.
Huang, Charles Q.
McCarthy, James R.
Grigoriadis, Dimitri E.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (17) : 5362 - 5362
[10] ASCPT Abstract PII-054: Effect of Complement Factor 5A Receptor 1 (C5AR1) Antagonist ACT-101-6450 on the Cytochrome P450 2C19 and 3A4 Substrates Omeprazole and Midazolam in a Cocktail Study in Healthy Subjects (vol 113, pg S5, 2023)
Janu, L.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 114 (03) : 721 - 721

← 1 →